Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.

Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study

Open access

Published version of a preprint

Abstract

Background: Dementia is an increasing public health threat worldwide. The pathogenesis of dementia has not been fully elucidated yet. Inflammatory processes are hypothesized to play an important role as a driver for cognitive decline but the origin of inflammation is not clear. We hypothesize that disturbances in gut microbiome composition, gut barrier dysfunction, bacterial translocation and resulting inflammation are associated with cognitive dysfunction in dementia. Methods: To test this hypothesis, a cohort of 23 patients with dementia and 18 age and sex matched controls without cognitive impairments were studied. Gut microbiome composition, gut barrier dysfunction, bacterial translocation and inflammation were assessed from stool and serum samples. Malnutrition was assessed by Mini Nutritional Assessment Short Form (MNA-SF), detailed information on drug use was collected. Microbiome composition was assessed by 16S rRNA sequencing, QIIME 2 and Calypso 7.14 tools. Results: Dementia was associated with dysbiosis characterized by differences in beta diversity and changes in taxonomic composition. Gut permeability was increased as evidenced by increased serum diamine oxidase (DAO) levels and systemic inflammation was confirmed by increased soluble cluster of differentiation 14 levels (sCD14). BMI and statin use had the strongest impact on microbiome composition. Conclusion: Dementia is associated with changes in gut microbiome composition and increased biomarkers of gut permeability and inflammation. Lachnospiraceae NK4A136 group as potential butyrate producer was reduced in dementia. Malnutrition and drug intake were factors, that impact on microbiome composition. Increasing butyrate producing bacteria and targeting malnutrition may be promising therapeutic targets in dementia. Trial registration: NCT03167983 .

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12877-020-01644-2

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Patient flow chart
Fig. 1 Patient flow chartCC BY · PubMed Central
Fig. 2 Differences in alpha and beta diversity in stool microbiome between dementia patients and controls a Alpha diversity (Chao1) in dementia patients and controls b Beta diversity (RDA) in dementia patients and controls c Alpha diversity between controls and different stages of cognitive dysfunction d Beta diversity (RDA) in controls and different stages of dementia
Fig. 2 Differences in alpha and beta diversity in stool microbiome between dementia patients and controls a Alpha diversity (Chao1) in dementia patients and controls b Beta diversity (RDA) in dementia patients and controls c Alpha diversity between controls and different stages of cognitive dysfunction d Beta diversity (RDA) in controls and different stages of dementiaCC BY · PubMed Central
Fig. 3 a Features selected by Linear discriminant analysis Effect Size (LEfSe) to discriminate between dementia patients and controls. b Differentially abundant taxa between dementia and controls
Fig. 3 a Features selected by Linear discriminant analysis Effect Size (LEfSe) to discriminate between dementia patients and controls. b Differentially abundant taxa between dementia and controlsCC BY · PubMed Central
Fig. 4 a Features selected by Linear discriminant analysis Effect Size (LEfSe) to discriminate between dementia different stages of cognitive dysfunction and controls. b Differentially abundant taxa between stages of cognitive dysfunction
Fig. 4 a Features selected by Linear discriminant analysis Effect Size (LEfSe) to discriminate between dementia different stages of cognitive dysfunction and controls. b Differentially abundant taxa between stages of cognitive dysfunctionCC BY · PubMed Central
Fig. 5 Network analysis to identify associations between bacteria and selected host variables. Taxa and explanatory variables are represented as nodes, taxa abundance as node size, and edges represent positive associations. Nodes (genera) are coloured based on their association with selected host variables (dementia/health, dementia stages, statin use or non-use, BMI). a whole cohort (n = 41), b dementia patients (n = 21)
Fig. 5 Network analysis to identify associations between bacteria and selected host variables. Taxa and explanatory variables are represented as nodes, taxa abundance as node size, and edges represent positive associations. Nodes (genera) are coloured based on their association with selected host variables (dementia/health, dementia stages, statin use or non-use, BMI). a whole cohort (n = 41), b dementia patients (n = 21)CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 71 references

Research works printed but not linked: 3

  1. Dementia. WHO fact sheet 2016.
  2. S3-Leitlinie Demenzen. 2016. Deutsche Gesellschaft für Neurologie, Hrsg. Leitlinien für Diagnostik und Therapie in der Neurologie.
  3. Rundel C, Cetinkaya-Rundel M, Clyde M, Banks D. statsr: Companion package for statistics with; 2018.

Cited by

See all 183

Metadata

Authors
Stadlbauer, V., Engertsberger, L., Komarova, I., Feldbacher, N., Leber, B., Pichler, G., Fink, N., Scarpatetti, M., Schippinger, W., Schmidt, R., & Horvath, A.
Affiliations
  • Medical University of Graz (AT)
  • Geriatrische Gesundheitszentren (AT)
Corresponding author
Stadlbauer, Vanessa
Venue
BMC Geriatrics
Published
2020-07-20
Volume
20
Issue
1
Pages
248-248
ISSN
1471-2318 (ISSN-L)
OpenAlex
W3043167826
Cited by
182
References
71
Citations by year
2026: 20 · 2025: 29 · 2024: 30 · 2023: 41 · 2022: 41 · 2021: 21
FWCI
8.35
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Geriatrics (publishedVersion, cc-by)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Österreichische Forschungsförderungsgesellschaft (Center for Biomarker Research in Medicine)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
dementia, gut dysbiosis, gut microbiota, intestinal barrier dysfunction, intestinal permeability, bacterial translocation, systemic inflammation, cognitive decline, malnutrition, statin use, butyrate-producing bacteria, Lachnospiraceae NK4A136, soluble CD14, diamine oxidase, body mass index
MeSH terms
Gastrointestinal Microbiome, Bacteria, Dementia, Feces, Humans, Inflammation, Pilot Projects, RNA, Ribosomal, 16S, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study. https://app.cochat.ai/papers/10.1186/s12877-020-01644-2
The paper
Stadlbauer, V., Engertsberger, L., Komarova, I., Feldbacher, N., Leber, B., Pichler, G., Fink, N., Scarpatetti, M., Schippinger, W., Schmidt, R., & Horvath, A. (2020). Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study. BMC Geriatrics. https://doi.org/10.1186/s12877-020-01644-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.